Opening Talk: Innovation and Technologies to Enhance the Care of Patients With Heart Failure
We Recommend
Disclosures
Within the last 24 months, I have had financial relationship(s) with the ineligible company or companies listed below:
- Grant Support/Research Contract - Abiomed; Ancora; Zoll
- Consultant Fee/Honoraria/Speaker's Bureau - Corvia; BackBeat Medical; Impulse Dynamics; BioMind; Zoll / Therox; Aquapass
- Equity/Stock(s)/Options - PVLoops LLC